Alpha Tau Medical (DRTS) Shares Outstanding (2020 - 2026)

Alpha Tau Medical has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $99.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 27.33% year-over-year to $99.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.1 million (up 27.33% YoY) and the FY2025 annual result came in at $89.0 million, up 15.24% from the prior year.
• Shares Outstanding (Entity) improved to $99.1 million in Q1 2026 per DRTS's latest filing, from $89.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $99.1 million in Q1 2026 and troughed at $33.8 million in Q2 2023.
• A 5-year average of $69.9 million and a median of $76.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) soared 69.81% in 2022, then slumped 47.34% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $70.2 million in 2022, then grew by 9.2% to $76.6 million in 2023, then climbed by 0.79% to $77.2 million in 2024, then increased by 15.24% to $89.0 million in 2025, then rose by 11.32% to $99.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $99.1 million, $89.0 million, and $87.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.